abstract |
Methods and compositions related to the use of a protein with kynureninase activity are described. For example, in certain aspects a modified kynureninase capable of degrading kynurenine can be described. In addition, certain aspects herein provide compositions and methods for treating kinurenine depleted cancer using the disclosed proteins or nucleic acids. |